a developer of novel therapies for the treatment of resistant bacterial infections
Industry Biotechnology
A.I.dvisor indicates that over the last year, SPRO has been loosely correlated with LXRX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRO jumps, then LXRX could also see price increases.
Ticker / NAME | Correlation To SPRO | 1D Price Change % | ||
---|---|---|---|---|
SPRO | 100% | -4.58% | ||
LXRX - SPRO | 39% Loosely correlated | -2.75% | ||
DNA - SPRO | 35% Loosely correlated | -15.00% | ||
XNCR - SPRO | 34% Loosely correlated | -0.47% | ||
ABOS - SPRO | 34% Loosely correlated | +3.16% | ||
CRSP - SPRO | 32% Poorly correlated | -5.90% | ||
More |
Ticker / NAME | Correlation To SPRO | 1D Price Change % |
---|---|---|
SPRO | 100% | -4.58% |
treatment theme (56 stocks) | 30% Poorly correlated | -1.02% |
novel medical theme (11 stocks) | 25% Poorly correlated | -1.33% |
pharmaceuticals theme (159 stocks) | 23% Poorly correlated | -1.90% |